Literature DB >> 12706816

Membrane topology of CLN3, the protein underlying Batten disease.

Qinwen Mao1, Brian J Foster, Haibin Xia, Beverly L Davidson.   

Abstract

Juvenile neuronal ceroid lipofuscinosis, or Batten disease, is an autosomal recessive disorder characterized by progressive loss of motor and cognitive functions, loss of vision, progressively severe seizures, and death. The disease is associated with mutations in the gene CLN3, which encodes a novel 438 amino acid protein, the function of which is currently unknown. Protein secondary structure prediction programs suggest that the CLN3 protein has five to seven membrane-spanning domains (MSDs). To distinguish among a number of hypothetical models for the membrane topology of CLN3 we used in vitro translation of native, Flag epitope-labeled and glycosylation site-mutated CLN3 protein in the presence or absence of canine pancreatic microsomes. These were immunoprecipitated using antibodies specific for Flag or peptide sequences within CLN3 or left untreated. The results indicate that CLN3 contains five MSDs, an extracellular/intraluminal amino-terminus, and a cytoplasmic carboxy-terminus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706816     DOI: 10.1016/s0014-5793(03)00284-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

1.  Two motifs target Batten disease protein CLN3 to lysosomes in transfected nonneuronal and neuronal cells.

Authors:  Aija Kyttälä; Gudrun Ihrke; Jouni Vesa; Michael J Schell; J Paul Luzio
Journal:  Mol Biol Cell       Date:  2003-12-29       Impact factor: 4.138

2.  Reptilian reovirus utilizes a small type III protein with an external myristylated amino terminus to mediate cell-cell fusion.

Authors:  Jennifer A Corcoran; Roy Duncan
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

Review 3.  Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses.

Authors:  Sara E Mole; Ruth E Williams; Hans H Goebel
Journal:  Neurogenetics       Date:  2005-09-28       Impact factor: 2.660

4.  Deletion of the Caenorhabditis elegans homologues of the CLN3 gene, involved in human juvenile neuronal ceroid lipofuscinosis, causes a mild progeric phenotype.

Authors:  G de Voer; P van der Bent; A J G Rodrigues; G-J B van Ommen; D J M Peters; P E M Taschner
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

5.  A novel deletion variant in CLN3 with highly variable expressivity is responsible for juvenile neuronal ceroid lipofuscinoses.

Authors:  Naser Gilani; Ehsan Razmara; Mehmet Ozaslan; Ihsan Kareem Abdulzahra; Saeid Arzhang; Ali Reza Tavasoli; Masoud Garshasbi
Journal:  Acta Neurol Belg       Date:  2021-03-30       Impact factor: 2.396

6.  CRISPR-Cas9-Mediated Correction of the 1.02 kb Common Deletion in CLN3 in Induced Pluripotent Stem Cells from Patients with Batten Disease.

Authors:  Erin R Burnight; Laura R Bohrer; Joseph C Giacalone; Darcey L Klaahsen; Heather T Daggett; Jade S East; Robert A Madumba; Kristan S Worthington; Robert F Mullins; Edwin M Stone; Budd A Tucker; Luke A Wiley
Journal:  CRISPR J       Date:  2018-02

7.  Interaction between Sdo1p and Btn1p in the Saccharomyces cerevisiae model for Batten disease.

Authors:  Seasson Phillips Vitiello; Jared W Benedict; Sergio Padilla-Lopez; David A Pearce
Journal:  Hum Mol Genet       Date:  2009-12-16       Impact factor: 6.150

8.  A novel role of the Batten disease gene CLN3: association with BMP synthesis.

Authors:  Judith A Hobert; Glyn Dawson
Journal:  Biochem Biophys Res Commun       Date:  2007-04-19       Impact factor: 3.575

9.  Phenotypic characterization of a mouse model of juvenile neuronal ceroid lipofuscinosis.

Authors:  Martin L Katz; Gary S Johnson; Gregory E Tullis; Bo Lei
Journal:  Neurobiol Dis       Date:  2007-09-07       Impact factor: 5.996

10.  Transmembrane protein topology prediction using support vector machines.

Authors:  Timothy Nugent; David T Jones
Journal:  BMC Bioinformatics       Date:  2009-05-26       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.